An open label comparative, multicentric study to assess the efficacy and safety of fixed dose combination capsules of Omeprazole and Cinitapride ER in comparison with Omeprazole capsules in patients suffering from non-ulcer dyspepsia (NUD) or gastroesophageal reflux disease (GERD).

Trial Profile

An open label comparative, multicentric study to assess the efficacy and safety of fixed dose combination capsules of Omeprazole and Cinitapride ER in comparison with Omeprazole capsules in patients suffering from non-ulcer dyspepsia (NUD) or gastroesophageal reflux disease (GERD).

Completed
Phase of Trial: Phase III

Latest Information Update: 02 Sep 2016

At a glance

  • Drugs Cinitapride/omeprazole (Primary) ; Omeprazole
  • Indications Gastro-oesophageal reflux; Non-ulcer dyspepsia
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Mar 2010 Status changed from active, no longer recruiting to completed as reported by Clinical Trials Registry - India
    • 08 Feb 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top